Publication:
Isolated abducens nerve palsy induced by vincristine therapy

dc.contributor.authorsToker, E; Yenice, O; Ogut, MS
dc.date.accessioned2022-03-12T17:16:33Z
dc.date.accessioned2026-01-11T13:34:23Z
dc.date.available2022-03-12T17:16:33Z
dc.date.issued2004
dc.description.abstractWe report a 28-year-old man with non-Hodgkin's lymphoma who presented with acute onset of diplopia 3 weeks after the completion of combination chemotherapy,with vincristine. He had a left esotropia with marked decrease in abduction. Magnetic resonance imaging scan of the brain showed thickening and enhancement of the left abducens nerve. Lymphomatous and other intracranial pathologies were excluded, and vincristine neurotoxicity was considered as the possible etiology of the abducens nerve palsy. His diplopia improved gradually, then completely resolved 4 weeks after the cessation of vincristine therapy. We concluded that isolated ocular muscle paresis can be the presenting sign of a toxic neuropathy associated with vincristine use.
dc.identifier.doi10.1016/j.jaapos.2003.07.011
dc.identifier.eissn1528-3933
dc.identifier.issn1091-8531
dc.identifier.pubmed14970804
dc.identifier.urihttps://hdl.handle.net/11424/227616
dc.identifier.wosWOS:000189276000014
dc.language.isoeng
dc.publisherMOSBY-ELSEVIER
dc.relation.ispartofJOURNAL OF AAPOS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleIsolated abducens nerve palsy induced by vincristine therapy
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage71
oaire.citation.issue1
oaire.citation.startPage69
oaire.citation.titleJOURNAL OF AAPOS
oaire.citation.volume8

Files